2022 PD Therapeutics Conference

*Please note that everyone must be fully vaccinated against COVID-19 in order to attend this meeting. You will be required to show proof of vaccination status at the door.

The Parkinson's Disease Therapeutics Conference is The Michael J. Fox Foundation's annual scientific conference and the only one in the world focused exclusively on Parkinson's disease drug development. The 14th Annual PD Therapeutics Conference is scheduled to be held on October 13, 2022, in-person, in New York.

Each year, the PD Therapeutics Conference brings together 300 research and business development professionals from both academia and industry and showcases the most exciting and innovative research from MJFF's research portfolio. Novel advances in basic and translational research from both academic and industry labs are highlighted through speaker presentations and a poster session. The event is a platform for field leaders to share new and unpublished results and for fostering new relationships and collaborations.

REGISTER HERE (Registration closes Tuesday, October 11 at 5 P.M. EST)

For Questions or Updates,

Please contact researchmeetings@michaeljfox.org.

Sohini Chowdhury, Deputy CEO |The Michael J. Fox Foundation 

Brian Fiske, PhD, Co-Chief Scientific Officer | The Michael J. Fox Foundation 

Roland Staal, PhD, Director of Pharmacology | Lucy Therapeutics 

Arthur A. Simen, MD, PhD, Executive Medical Director | Takeda Development Center Americas

Kenneth Marek, MD, President | Institute for Neurodegenerative Disorders 

Stacie Weninger, PhD, President | FBRI 

Kevin McFarthing, PhD | Research Advocate  

Mark Frasier, PhD, Co-Chief Scientific Officer | The Michael J. Fox Foundation 

Lana Chahine, MD, Assistant Professor of Neurology | University of Pittsburgh 

John Seibyl, MD, Co-Founder & Chairman | Institute for Neurodegenerative Disorders 

Josh Cosman, Director, Digital Health Strategy | AbbVie 

Glenn Stebbins, PhD, Professor Emeritus | Rush University Medical Center 

Tanya Simuni, MD | Arthur C. Nielsen Jr. Professor of Neurology | Director, Parkinson’s Disease and Movement Disorders Center | Northwestern University Feinberg School of Medicine 

Catherine Kopil, PhD, Senior Vice President | The Michael J. Fox Foundation 

Shalini Padmanabhan, PhD, Vice President | The Michael J. Fox Foundation 

Fiona Elwood, PhD, Vice President Neurodegeneration Disease Area Stronghold Leader | Janssen Pharmaceuticals

Nicholas Wood, MbChB, PhD, FRCP, FMedSci | UCL Queen Square Institute of Neurology 

Manuela Polydoro, PhD, Head of Translational Medicine | Muna Therapeutics 

Jim Sullivan, PhD,  Co-Founder & CEO| Vanqua Bio, Venture Partner, OrbiMed 

Jimmy Choi | Patient Council Member, The Michael J. Fox Foundation

Interested in Sponsorship Opportunities?

Contact our Research Alliances team at researchpartnerships@michaeljfox.org for information about 2022 sponsorship opportunities. 

Address

Convene Conference Center
117 W 46th St 
New York, NY 10036

Convene at 117 West 46th Street is our largest event venue in Midtown West Manhattan. Located between Times Square and Rockefeller Center, it’s the ideal space (up to 600 guests) for your next summit, awards dinner, town hall, or gala. As one of Convene's flagship properties, this space offers "white-box" design capability. Professional meeting planners are provided with the ability to customize the space with multiple sponsor and corporate branding opportunities with our digital video walls, physical exhibit areas, columns, and walls.

*Please note that Convene requires all attendees and staff to be fully vaccinated against COVID-19 in order to attend a meeting at their facility. You will be required to show proof of vaccination status at the door.